Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Precision Biosciences Inc (DTIL)  
$10.64 0.29 (2.65%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 110,820,000
Market Cap: 1.18(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $8.58 - $25.88
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Precision Biosciences is a clinical stage gene editing company focused on improving life by developing ex vivo allogeneic chimeric antigen receptor (CAR) T immunotherapies and in vivo therapies for genetic and infectious diseases with the application of its wholly owned proprietary ARCUS genome editing platform. Co. is simultaneously conducting a Phase 1/2a clinical trial evaluating PBCAR0191 as a potential first-in-class and a Phase 1 clinical trial evaluating PBCAR19B as, if approved, a potential CD19-targeting CAR T cell therapies in adult patients with relapsed or refractory, B-cell malignancies.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 90,000 189,021
Total Buy Value $0 $0 $43,200 $170,792
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 5
Total Shares Sold 2,480 210,683 365,092 452,513
Total Sell Value $25,523 $100,755 $167,195 $249,561
Total People Sold 4 4 4 4
Total Sell Transactions 5 9 12 17
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 179
  Page 4 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Barton Shane VP & Corporate Controller   •       –      –    2022-02-28 4 A $3.61 $2,747 D/D 761 2,659     -
   Scimeca Dario General Counsel and Secretary   •       –      –    2022-02-28 4 A $3.61 $7,397 D/D 2,049 10,573     -
   Kelly John Alexander Chief Financial Officer   •       –      –    2021-08-31 4 A $10.68 $10,659 D/D 998 16,798     -
   Barton Shane VP & Corporate Controller   •       –      –    2021-08-31 4 A $10.68 $6,451 D/D 604 1,898     -
   Scimeca Dario General Counsel and Secretary   •       –      –    2021-08-31 4 A $10.68 $5,853 D/D 548 8,524     -
   Thomson David S. Chief Operating Officer   •       –      –    2021-06-23 4 S $10.65 $319,500 D/D (30,000) 111,513 11%     
   Thomson David S. Chief Operating Officer   •       –      –    2021-06-23 4 OE $1.18 $35,400 D/D 30,000 141,513     -
   Thomson David S. Chief Operating Officer   •       –      –    2021-06-21 4 S $10.77 $161,550 D/D (15,000) 111,513 13%     
   Thomson David S. Chief Operating Officer   •       –      –    2021-06-21 4 OE $1.18 $17,700 D/D 15,000 126,513     -
   Thomson David S. Chief Operating Officer   •       –      –    2021-06-18 4 S $11.00 $110,000 D/D (10,000) 111,513 8%     
   Thomson David S. Chief Operating Officer   •       –      –    2021-06-18 4 OE $1.18 $11,800 D/D 10,000 121,513     -
   Thomson David S. Chief Operating Officer   •       –      –    2021-06-17 4 S $10.44 $104,400 D/D (10,000) 111,513 10%     
   Thomson David S. Chief Operating Officer   •       –      –    2021-06-17 4 OE $1.18 $11,800 D/D 10,000 121,513     -
   Thomson David S. Chief Operating Officer   •       –      –    2021-06-11 4 S $11.52 $345,600 D/D (30,000) 111,513 14%     
   Thomson David S. Chief Operating Officer   •       –      –    2021-06-11 4 OE $1.18 $35,400 D/D 30,000 141,513     -
   Jantz Derek Chief Scientific Officer   •       •      –    2021-05-17 4 S $9.38 $187,600 D/D (20,000) 4,032,279 -35%     
   Jantz Derek Chief Scientific Officer   •       •      –    2021-05-14 4 AS $9.17 $88,701 D/D (9,673) 4,052,279 42%     
   Jantz Derek Chief Scientific Officer   •       •      –    2021-05-14 4 OE $0.04 $861 D/D 21,514 4,061,952     -
   Jantz Derek Chief Scientific Officer   •       •      –    2021-05-13 4 AS $9.15 $88,508 D/D (9,673) 4,040,438 38%     
   Jantz Derek Chief Scientific Officer   •       •      –    2021-05-13 4 OE $0.04 $861 D/D 21,514 4,050,111     -
   Kane Matthew R. President and CEO   •       •      –    2021-05-13 4 AS $8.96 $86,688 D/D (9,675) 2,013,597 38%     
   Kane Matthew R. President and CEO   •       •      –    2021-05-13 4 OE $0.04 $861 D/D 21,514 2,023,272     -
   Jantz Derek Chief Scientific Officer   •       •      –    2021-05-12 4 AS $8.72 $84,375 D/D (9,676) 4,028,597 40%     
   Jantz Derek Chief Scientific Officer   •       •      –    2021-05-12 4 OE $0.04 $861 D/D 21,514 4,038,273     -
   Kane Matthew R. President and CEO   •       •      –    2021-05-10 4 AS $8.25 $80,405 D/D (9,746) 2,001,758 59%     

  179 Records found
  1  2  3  4  5  6  7  8   
  Page 4 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed